Skip to main content
. 2021 Jun 11;63(12):2023–2033. doi: 10.1007/s00234-021-02737-4

Table 4.

Baseline characteristics — case patients

Nr Sex Age Tumour type Treatment preceding ASL Best response (mo) Time ASL-MP (d) Time surgery 1-MP (mo) Time MRI-surgery 2 (d) Seizures ASL
1 W 43 ODG 1p/19q-codel, IDH mt No N/A 17 42 No 2nd surgery Yes 2
2 M 48 DA IDH mt No N/A 18 12 No contrast-enhancement on follow-up MRI No 1
3 M 26 DA IDH mt TMZ 9 cycles SD (24) 112 33 No 2nd surgery No 1
4 W 55 DA IDH wt RT 50.4 Gy, TMZ 12 cycles SD (7) 203 17 No 2nd surgery Yes 0
5 W 45 DA IDH mt RT 50.4 Gy SD (36) 100 44 No 2nd surgery No 0
6 M 57 DA IDH mt RT 50.4 Gy, TMZ 12 cycles PR (4) 31 23 No 2nd surgery No 2
7 W 49 DA IDH mt RT 50.4 Gy, TMZ 9 cycles MR (11) 85 116 1 Yes 1
8 M 47 DG-NOS RT 50.4 Gy SD (20) 86 37 No 2nd surgery No 0
9 M 50 DA IDH wt RT 50.4 Gy, TMZ 14 cycles PR (17) 135 37 18 No 1
10 W 25 DA IDH mt RT 50.4 Gy, TMZ 6 cycles SD (47) 188 111 258 Yes 1
11 M 49 DG-NOS TMZ 3 cycles TP 116 3 No 2nd surgery No 1

Nr, number of case patient; W, woman; M, man; ODG 1p/19q-codel, 1p/19q-codeleted oligodendroglioma; DA, diffuse astrocytoma; IDH, Isocitrate dehydrogenase; mt, mutated; wt, wildtype; DG-NOS, diffuse glioma not otherwise specified; RT, radiotherapy; TMZ, temozolomide; Gy, Gray; Best response: best response to treatment using RANO criteria in months [8]; SD, stable disease; PR, partial response; MR, minor response; TP, tumour progression; N/A, not applicable; Time ASL-MP (d), time from index ASL-MRI to malignant progression in days; ASL, arterial spin labeling MRI; Time surgery 1- MP (mo), time from first surgery to malignant progression in months; Time MRI – surgery 2 (d), time from MRI showing MP to second surgery in days (recurrence-resection), Seizures, seizures before ASL; ASL, score ASL of first radiologist.